MYC and central nervous system cancer: H3-K27M gliomas show high expression of MYC and MYC target genes, due to both epigenetic alterations and structural variants, resulting in a viability dependency on MYC signaling (Krug et al., 2019; Pajovic et al., 2020; Dubois et al., 2022).